STALICLA appoints Stéphane Baudouin as Chief of Science

Neurobiologist with ten years’ Autism Spectrum Disorder experience takes on the lead research strategy role at the Swiss biotech. Geneva & Barcelona – STALICLA is delighted to announce the appointment of Stéphane Baudouin as Chief of Science effective from October 10, 2019. Stéphane takes over as Chief of Science from Luigi Boccuto, who will continue as Assistant …

STALICLA appoints Stéphane Baudouin as Chief of Science Read More »

STALICLA’s CEO & Founder, speaker at the Royal Netherlands Academy of Sciences Colloquium – October 2-3 2019

STALICLA’S CEO & Founder, Lynn Durham invited as a speaker to the Royal Netherlands Academy of Arts and Sciences Colloquium on Neurodevelopmental Disorders  – October 2-3 2019 Lynn Durham has been invited as a speaker together with a group of world leading experts at the prestigious Royal Netherlands Academy to participate in its Colloquium entitled “A …

STALICLA’s CEO & Founder, speaker at the Royal Netherlands Academy of Sciences Colloquium – October 2-3 2019 Read More »

Lynn Durham to present at the SACHS Associates Biotech in Europe Forum, Basel – September 25-26

STALICLA to present at the SACHS Associates Biotech in Europe Forum, Basel – September 25-26 CEO, Lynn Durham, will represent STALICLA at the 19thAnnual Biotech in Europe Forum. Lynn will be speaking on day 1, with a company presentation (14:00 – 14:15 CET, 25thSeptember) and as a Panellist on the Neurosciences Panel 1 (16:05 – …

Lynn Durham to present at the SACHS Associates Biotech in Europe Forum, Basel – September 25-26 Read More »

SOPHiA GENETICS Expands Executive Team with a Chief Marketing Officer and New Chief Information Officer

Lausanne, Switzerland, and Boston, United States, September 19, 2019: SOPHiA GENETICS, leader in Data-Driven Medicine, announced today that Gaëtan Fraikin and Sergei Yakneen have joined its executive team as Chief Marketing Officer and Chief Information Officer, respectively. Mr. Fraikin and Mr. Yakneen bring decades of highly specialized experience from key players in the health tech industry. …

SOPHiA GENETICS Expands Executive Team with a Chief Marketing Officer and New Chief Information Officer Read More »

Distalmotion announces successful completion of cadaver study, confirming Dexter’s core value proposition of removing complexity out of robotic surgery to fast track its adoption in minimally invasive surgical care

Major milestone towards go-to market for Distalmotion’s surgical robot Dexter Lausanne, Switzerland, 29 August 2019: Distalmotion, a Swiss-based medical device company removing the complexity out of robotic surgery to fast track its widespread adoption in minimally invasive surgical care, announced today the successful completion of its latest cadaver study involving Dexter, its surgical robot developed …

Distalmotion announces successful completion of cadaver study, confirming Dexter’s core value proposition of removing complexity out of robotic surgery to fast track its adoption in minimally invasive surgical care Read More »

Spearheading a paradigm shift in robotic surgery: Michael Friedrich discusses Dexter at Viszeralchirurgische Tage 2019 in Bonn, Germany

Study to identify genomic markers associated with clinical response to ADCT-402 (loncastuximab tesirine) inrelapsed or refractory diffuse large B-cell lymphoma (DLBCL) Lausanne, Switzerland, August 6, 2019– ADC Therapeutics, an oncology drug discovery and development company that specializes in the development of antibody drug conjugates (ADCs), and SOPHiA GENETICS, a leader in Data-Driven Medicine, today announced they …

Spearheading a paradigm shift in robotic surgery: Michael Friedrich discusses Dexter at Viszeralchirurgische Tage 2019 in Bonn, Germany Read More »

Spearheading a paradigm shift in robotic surgery: Michael Friedrich discusses Dexter at Viszeralchirurgische Tage 2019 in Bonn, Germany

May 8, 2019  On May 9-10 our CEO, Michael Friedrich, is attending the Viszeralchirurgische Tage 2019 event at the Center of Advanced European Studies and Research (caesar) in Bonn, Germany to outline the paradigm shift in robotic surgery that Dexter spearheads and stands for. Dexter is designed to maintain laparoscopic workflows; bringing surgeons back to …

Spearheading a paradigm shift in robotic surgery: Michael Friedrich discusses Dexter at Viszeralchirurgische Tage 2019 in Bonn, Germany Read More »